Top

Published in:

Open Access 01-06-2009 | Commentary

Obesity and impaired renal function: potential for lifestyle intervention?

Authors: Eva Corpeleijn, Stephan J. L. Bakker, Ronald P. Stolk

Published in: European Journal of Epidemiology | Issue 6/2009

Abstract

Obesity is recently acknowledged as an important independent risk factor for kidney disease, in which epidemiological evidence played a crucial role. This risk is probably explained by intracellular lipid accumulation in the kidney. Lifestyle factors such as physical activity and diet play a role in the development of kidney disease in several stages: development of obesity and the metabolic syndrome, occurrence of obesity-related glomerulopathy, improvement of hemodialysis patients, and prevention of graft dysfunction and graft loss after renal transplantation. After the recent success of lifestyle intervention to prevent diabetes, further research is needed to show the effects of lifestyle changes to prevent and reduce obesity-related morbidity, including chronic kidney disease.

Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis. 1998;32(5):853–906. doi:10.1016/S0272-6386(98)70145-3.PubMedCrossRef

de Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker, and a new target for therapy. Kidney Int Suppl. 2005;68:S25–9. doi:10.1111/j.1523-1755.2005.09805.x.CrossRef

Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis. 2003;41(1):1–12. doi:10.1053/ajkd.2003.50007.PubMedCrossRef

Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001;59(4):1498–509. doi:10.1046/j.1523-1755.2001.0590041498.x.PubMedCrossRef

Bakker SJ, Gansevoort RT, de Zeeuw D. Metabolic syndrome: a fata morgana? Nephrol Dial Transplant. 2007;22(1):15–20. doi:10.1093/ndt/gfl581.PubMedCrossRef

Kronborg J, Jenssen T, Njolstad I, Toft I, Eriksen BO. Metabolic risk factors associated with serum creatinine in a non-diabetic population. Eur J Epidemiol. 2007;22(10):707–13. doi:10.1007/s10654-007-9164-8.PubMedCrossRef

Rathmann W, Haastert B, Icks A, Giani G, Roseman JM. Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study. Eur J Epidemiol. 2007;22(7):439–45. doi:10.1007/s10654-007-9132-3.PubMedCrossRef

Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19–33. doi:10.1038/sj.ki.5002586.PubMedCrossRef

Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17(6):1695–702. doi:10.1681/ASN.2005060638.PubMedCrossRef

10.

Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004;65(5):1870–6. doi:10.1111/j.1523-1755.2004.00582.x.PubMedCrossRef

11.

Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21–8.PubMed

12.

Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005;16(7):2134–40. doi:10.1681/ASN.2005010106.PubMedCrossRef

13.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med. 1999;130(6):461–70.PubMed

14.

Oterdoom LH, van Ree RM, de Vries AP, Gansevoort RT, Schouten JP, van Son WJ, et al. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients. Transplantation. 2008;86(3):391–8. doi:10.1097/TP.0b013e3181788aea.PubMedCrossRef

15.

van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D, de Jong PE, et al. Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol. 2009 Feb 11.

16.

Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med. 1974;81(4):440–7.PubMed

17.

Deji N, Kume S, Araki SI, Soumura M, Sugimoto T, Isshiki K, et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol. 2008 Oct 29.

18.

Jiang T, Liebman SE, Lucia MS, Li J, Levi M. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int. 2005;68(6):2608–20. doi:10.1111/j.1523-1755.2005.00733.x.PubMedCrossRef

19.

Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol. 2007;27(1):44–54. doi:10.1159/000098955.PubMedCrossRef

20.

Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006;26(3):232–44. doi:10.1159/000093632.PubMedCrossRef

21.

ter Maaten JC, Bakker SJ, Serne EH, ter Wee PM, Donker AJ, Gans RO. Insulin’s acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin’s acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol Dial Transplant. 1999;14(10):2357–63. doi:10.1093/ndt/14.10.2357.PubMedCrossRef

22.

ter Maaten JC, Bakker SJ, Serne EH, Moshage HJ, Donker AJ, Gans RO. Insulin-mediated increases in renal plasma flow are impaired in insulin-resistant normal subjects. Eur J Clin Invest. 2000;30(12):1090–8. doi:10.1046/j.1365-2362.2000.00749.x.PubMedCrossRef

23.

Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int. 2004;65(1):259–65. doi:10.1111/j.1523-1755.2004.00351.x.PubMedCrossRef

24.

Bosma RJ, Krikken JA, van der Heide HJJ, de Jong PE, Navis GJ. Obesity and renal hemodynamics. Contrib Nephrol. 2006;151:184–202. doi:10.1159/000095329.PubMedCrossRef

25.

Bruce CR, Hawley JA. Improvements in insulin resistance with aerobic exercise training: a lipocentric approach. Med Sci Sports Exerc. 2004;36(7):1196–201.PubMed

26.

Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004;23(4):447–56. doi:10.1016/j.clnu.2004.02.006.PubMedCrossRef

27.

Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, et al. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia. 2006;49(10):2392–401. doi:10.1007/s00125-006-0383-4.PubMedCrossRef

28.

Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14(4):479–87.PubMed

29.

Porrini E, Delgado P, Bigo C, Alvarez A, Cobo M, Checa MD, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis. 2006;48(1):134–42. doi:10.1053/j.ajkd.2006.04.078.PubMedCrossRef

30.

Bosma RJ, Kwakernaak AJ, van der Heide JJ, de Jong PE, Navis GJ. Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact. Am J Transplant. 2007;7(3):645–52. doi:10.1111/j.1600-6143.2006.01672.x.PubMedCrossRef

31.

Jezior D, Krajewska M, Madziarska K, Regulska-Ilow B, Ilow R, Janczak D, et al. Weight reduction in renal transplant recipients program: the first successes. Transplant Proc. 2007;39(9):2769–71. doi:10.1016/j.transproceed.2007.08.055.PubMedCrossRef

32.

de Francisco AL, Fresnedo GF, Palomar R, Pinera C, Arias M. The renal benefits of a healthy lifestyle. Kidney Int Suppl. 2005;68:S2–6. doi:10.1111/j.1523-1755.2005.09901.x.CrossRef

33.

Geleijnse JM, Witteman JC, Stijnen T, Kloos MW, Hofman A, Grobbee DE. Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam study. Eur J Epidemiol. 2007;22(11):763–70. doi:10.1007/s10654-007-9186-2.PubMedCrossRef

34.

Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GL, et al. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol. 2006;26(3):268–75. doi:10.1159/000093833.PubMedCrossRef

35.

Moinuddin I, Leehey DJ. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Adv Chronic Kidney Dis. 2008;15(1):83–96. doi:10.1053/j.ackd.2007.10.004.PubMedCrossRef

36.

van Vilsteren MC, de Greef MH, Huisman RM. The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant. 2005;20(1):141–6. doi:10.1093/ndt/gfh560.PubMedCrossRef

37.

Kramer H, Luke A. Obesity and kidney disease: a big dilemma. Curr Opin Nephrol Hypertens. 2007;16(3):237–41. doi:10.1097/MNH.0b013e32803578e4.PubMedCrossRef

38.

Roumen C, Corpeleijn E, Feskens EJ, Mensink M, Saris WH, Blaak EE. Impact of 3 year lifestyle intervention on postprandial glucose metabolism: the SLIM study. Diabet Med. 2008;25(5):597–605. doi:10.1111/j.1464-5491.2008.02417.x.PubMedCrossRef

39.

Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403. doi:10.1056/NEJMoa012512.PubMedCrossRef

40.

Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet. 2006;368(9548):1673–9. doi:10.1016/S0140-6736(06)69701-8.PubMedCrossRef

41.

Mensink M, Corpeleijn E, Feskens EJ, Kruijshoop M, Saris WH, de Bruin TW, et al. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Res Clin Pract. 2003;61(1):49–58. doi:10.1016/S0168-8227(03)00067-6.PubMedCrossRef

42.

Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334(7588):299. doi:10.1136/bmj.39063.689375.55.PubMedCrossRef

43.

Roumen C, Blaak EE, Corpeleijn E. Lifestyle intervention in the prevention of diabetes: determinants of success for future implementation. Nutr Rev. 2009;67(3):132–46.PubMedCrossRef

44.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 Suppl 1(2):S1–266.

45.

Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, Slaets JP, et al. Universal risk factors for multifactorial diseases: lifelines: a three-generation population-based study. Eur J Epidemiol. 2008;23(1):67–74. doi:10.1007/s10654-007-9204-4.PubMedCrossRef

Title: Obesity and impaired renal function: potential for lifestyle intervention?
Authors: Eva Corpeleijn
Stephan J. L. Bakker
Ronald P. Stolk
Publication date: 01-06-2009
Publisher: Springer Netherlands
Published in: European Journal of Epidemiology / Issue 6/2009
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-009-9345-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Obesity and impaired renal function: potential for lifestyle intervention?

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2009

Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study

Unfavourable risk factors for type 2 diabetes mellitus are already apparent more than a decade before onset in a population-based study of older persons: from the Age, Gene/Environment Susceptibility—Reykjavik Study (AGES-Reykjavik)

Bone mineral density at the hip in Norwegian women and men—prevalence of osteoporosis depends on chosen references: the Tromsø Study

Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort

The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia

Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study